The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Divekar, A. A.
Right arrow Articles by Mosmann, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Divekar, A. A.
Right arrow Articles by Mosmann, T. R.
The Journal of Immunology, 2006, 176: 1465-1473.
Copyright © 2006 by The American Association of Immunologists

Protein Vaccines Induce Uncommitted IL-2-Secreting Human and Mouse CD4 T Cells, Whereas Infections Induce More IFN-{gamma}-Secreting Cells1

Anagha A. Divekar*, Dietmar M. W. Zaiss*, F. Eun-Hyung Lee{dagger}, Dacheng Liu{ddagger}, David J. Topham*, Alice J. A. M. Sijts* and Tim R. Mosmann2,*

* David H. Smith Center for Vaccine Biology and Immunology, and Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642; {dagger} Department of Medicine, University of Rochester, University of Rochester, Rochester, NY 14642; and {ddagger} Department of Biostatistics and Computational Biology, University of Rochester, University of Rochester, Rochester, NY 14642

Mouse and human CD4 T cells primed during an immune response may differentiate into effector phenotypes such as Th1 (secreting IFN-{gamma}) or Th2 (secreting IL-4) that mediate effective immunity against different classes of pathogen. However, primed CD4 T cells can also remain uncommitted, secreting IL-2 and chemokines, but not IFN-{gamma} or IL-4. We now show that human CD4 T cells primed by protein vaccines mostly secreted IL-2, but not IFN-{gamma}, whereas in the same individuals most CD4 T cells initially primed by infection with live pathogens secreted IFN-{gamma}. We further demonstrate that many tetanus-specific IL-2+IFN-{gamma} cells are uncommitted and that a single IL-2+IFN-{gamma} cell can differentiate into Th1 or Th2 phenotypes following in vitro stimulation under appropriate polarizing conditions. In contrast, influenza-specific IL-2+IFN-{gamma} CD4 cells maintained a Th1-like phenotype even under Th2-polarizing conditions. Similarly, adoptively transferred OTII transgenic mouse T cells secreted mainly IL-2 after priming with OVA in alum, but were biased toward IFN-{gamma} secretion when primed with the same OVA peptide presented as a pathogen Ag during live infection. Thus, protein subunit vaccines may prime a unique subset of differentiated, but uncommitted CD4 T cells that lack some of the functional properties of committed effectors induced by infection. This has implications for the design of more effective vaccines against pathogens requiring strong CD4 effector T cell responses.




This article has been cited by other articles:


Home page
J. Immunol.Home page
N. H. R. Litjens, M. Huisman, D. Hijdra, B. M. N. Lambrecht, K. J. Stittelaar, and M. G. H. Betjes
IL-2 Producing Memory CD4+ T Lymphocytes Are Closely Associated with the Generation of IgG-Secreting Plasma Cells
J. Immunol., September 1, 2008; 181(5): 3665 - 3673.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Adeeku, P. Gudapati, Y. Mendez-Fernandez, L. Van Kaer, and M. Boothby
Flexibility accompanies commitment of memory CD4 lymphocytes derived from IL-4 locus-activated precursors
PNAS, July 8, 2008; 105(27): 9307 - 9312.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Bansal, B. Jackson, K. West, S. Wang, S. Lu, J. S. Kennedy, and P. A. Goepfert
Multifunctional T-Cell Characteristics Induced by a Polyvalent DNA Prime/Protein Boost Human Immunodeficiency Virus Type 1 Vaccine Regimen Given to Healthy Adults Are Dependent on the Route and Dose of Administration
J. Virol., July 1, 2008; 82(13): 6458 - 6469.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. A. Shaw and M. N. Starnbach
Both CD4+ and CD8+ T Cells Respond to Antigens Fused to Anthrax Lethal Toxin
Infect. Immun., June 1, 2008; 76(6): 2603 - 2611.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. J. Ramos, A. M. Davis, T. C. George, and J. D. Farrar
IFN-{alpha} Is Not Sufficient to Drive Th1 Development Due to Lack of Stable T-bet Expression
J. Immunol., September 15, 2007; 179(6): 3792 - 3803.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. C. Tilton, M. R. Luskin, A. J. Johnson, M. Manion, C. W. Hallahan, J. A. Metcalf, M. McLaughlin, R. T. Davey Jr., and M. Connors
Changes in Paracrine Interleukin-2 Requirement, CCR7 Expression, Frequency, and Cytokine Secretion of Human Immunodeficiency Virus-Specific CD4+ T Cells Are a Consequence of Antigen Load
J. Virol., March 15, 2007; 81(6): 2713 - 2725.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Stubbe, N. Vanderheyde, M. Goldman, and A. Marchant
Antigen-Specific Central Memory CD4+ T Lymphocytes Produce Multiple Cytokines and Proliferate In Vivo in Humans
J. Immunol., December 1, 2006; 177(11): 8185 - 8190.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. J. Kobie, P. R. Shah, L. Yang, J. A. Rebhahn, D. J. Fowell, and T. R. Mosmann
T Regulatory and Primed Uncommitted CD4 T Cells Express CD73, Which Suppresses Effector CD4 T Cells by Converting 5'-Adenosine Monophosphate to Adenosine
J. Immunol., November 15, 2006; 177(10): 6780 - 6786.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. A. Diaz and D. M. Koelle
Human CD4+ CD25high Cells Suppress Proliferative Memory Lymphocyte Responses to Herpes Simplex Virus Type 2.
J. Virol., August 1, 2006; 80(16): 8271 - 8273.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.